囊性纤维化患者中雾化器的微生物污染
Cansu Yilmaz Yegit1, Pinar Ergenekon1, Nurcan Duman2
1Department of Pediatric Pulmonology, Marmara University School of Medicine, İstanbul, Türkiye.
Turkish archives of pediatrics
|January 13, 2025
概括
囊性纤维化患者的雾化剂污染率为40.2%,其中室内受影响最大. 尽管污染的致病率低,但所有囊性纤维化中心都建议改善雾化器卫生教育.
科学领域:
- 微生物学 微生物学
- 肺部病理学 肺部病理学
- 传染性疾病 传染性疾病
背景情况:
- 雾化器污染对呼吸系统健康构成风险,特别是在免疫功能低下的患者中.
- 囊性纤维化 (CF) 患者在药物输送中严重依赖雾化器,增加暴露潜力.
- 了解雾化器微生物概况和卫生实践对于CF的感染控制至关重要.
研究的目的:
- 为了确定囊性纤维化患者使用的雾化器的污染状况.
- 评估患者卫生实践与微生物污染水平之间的联系.
- 为了识别在雾化器表面发现的常见微生物.
主要方法:
- 从102名CF患者的雾化器中采集的微生物扫描样本.
- 来自三个不同的雾化器站点的污染分析.
- 基于问卷对患者雾化器卫生实践的评估.
主要成果:
- 观察到的污染率为40.2%,雾化器室是最常被污染的地方.
- 细菌污染发生在37.3%的样本中,主要是阴性生物.
- 大多数确定的生物是环境或共生植物,具有较低的致病潜力.
结论:
- 在这种囊性纤维化队列中,雾化器被致病微生物污染并不常见.
- 患者当前的卫生实践不足以对其影响进行可靠的分析.
- 针对雾化器卫生的有针对性的教育计划对于所有囊性纤维化中心至关重要.
相关概念视频
Cystic Fibrosis: Management
139
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
139
Cystic Fibrosis: Pathogenesis
184
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
184
Transmission-based Precautions II: Airborne and Protective Environment
1.2K
Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
1.2K
Inhaled Medications
236
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
236
Sputum Studies II: Culture and Sensitivity
249
Description
Sputum culture and sensitivity is a medical procedure used to diagnose bacterial infections in the respiratory tract and select the most appropriate antibiotics for treatment. This process involves analyzing sputum samples of thick and opaque secretions produced in the lungs and airways. These samples are collected from patients and then sent to the laboratory for analysis.
The test can identify various pathogens responsible for respiratory infections, including Streptococcus,...
Sputum culture and sensitivity is a medical procedure used to diagnose bacterial infections in the respiratory tract and select the most appropriate antibiotics for treatment. This process involves analyzing sputum samples of thick and opaque secretions produced in the lungs and airways. These samples are collected from patients and then sent to the laboratory for analysis.
The test can identify various pathogens responsible for respiratory infections, including Streptococcus,...
249


